A fruitful alliance: the synergy between and in bacterial vaginosis-associated biofilm.

Liselotte Hardy, Vicky Jespers, Said Abdellati, Irith De Baetselier, Lambert Mwambarangwe, Viateur Musengamana, Janneke van de Wijgert, Mario Vaneechoutte, Tania Crucitti
Author Information
  1. Liselotte Hardy: HIV and Sexual Health Group, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  2. Vicky Jespers: HIV and Sexual Health Group, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  3. Said Abdellati: STI Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  4. Irith De Baetselier: STI Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. ORCID
  5. Lambert Mwambarangwe: Rinda Ubuzima, Kigali, Rwanda.
  6. Viateur Musengamana: Rinda Ubuzima, Kigali, Rwanda.
  7. Janneke van de Wijgert: Rinda Ubuzima, Kigali, Rwanda.
  8. Mario Vaneechoutte: Laboratory Bacteriology Research, Faculty of Medicine & Health Sciences, University of Ghent, Ghent, Belgium.
  9. Tania Crucitti: STI Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Abstract

OBJECTIVES: Bacterial vaginosis (BV) is characterised by a change in the microbial composition of the vagina. The BV-associated organisms outnumber the health-associated species and form a polymicrobial biofilm on the vaginal epithelium, possibly explaining the difficulties with antibiotic treatment. A better understanding of vaginal biofilm with emphasis on and may contribute to a better diagnosis and treatment of BV.
METHODS: To this purpose, we evaluated the association between the presence of both bacteria by fluorescence in situ hybridisation (FISH) and BV by Nugent scoring in 463 vaginal slides of 120 participants participating in a clinical trial in Rwanda.
RESULTS: A bacterial biofilm was detected in half of the samples using a universal bacterial probe. The biofilm contained in 54.1% and in 82.0% of the samples. was accompanied by in 99.5% of samples. The odds of having a Nugent score above 4 were increased for samples with dispersed and/or present (OR 4.5; CI 2 to 10.3). The probability of having a high Nugent score was even higher when a combination of adherent and dispersed was visualised (OR 75.6; CI 13.3 to 429.5) and highest when both bacteria were part of the biofilm (OR 119; CI 39.9 to 360.8).
CONCLUSIONS: Our study, although not comprehensive at studying the polymicrobial biofilm in BV, provided a strong indication towards the importance of and the symbiosis of and in this biofilm.
TRIAL REGISTRATION NUMBER: NCT01796613.

Keywords

Associated Data

ClinicalTrials.gov | NCT01796613

References

  1. BMC Infect Dis. 2004 Feb 13;4:5 [PMID: 15018635]
  2. J Infect Dis. 2006 Sep 15;194(6):828-36 [PMID: 16941351]
  3. Am J Obstet Gynecol. 2004 Oct;191(4):1130-2 [PMID: 15507931]
  4. J Clin Microbiol. 1991 Feb;29(2):297-301 [PMID: 1706728]
  5. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 2):441-5 [PMID: 8357040]
  6. J Appl Microbiol. 2001 Feb;90(2):180-9 [PMID: 11168720]
  7. PLoS One. 2015 Aug 25;10(8):e0136658 [PMID: 26305575]
  8. J Infect Dis. 1989 Sep;160(3):490-6 [PMID: 2668431]
  9. BMC Infect Dis. 2015 Mar 04;15:115 [PMID: 25879811]
  10. BMC Microbiol. 2004 Apr 21;4:16 [PMID: 15102329]
  11. BMC Public Health. 2015 Apr 10;15:348 [PMID: 25880636]
  12. J Infect Dis. 2015 Dec 15;212(12):1856-61 [PMID: 26080369]
  13. PLoS One. 2012;7(6):e37818 [PMID: 22719852]
  14. Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25 [PMID: 25596784]
  15. Obstet Gynecol. 2005 Nov;106(5 Pt 1):1013-23 [PMID: 16260520]
  16. Microbiology. 2010 Feb;156(Pt 2):392-9 [PMID: 19910411]
  17. PLoS One. 2014 Aug 22;9(8):e105998 [PMID: 25148517]
  18. Res Microbiol. 2016 Feb-Mar;167(2):133-41 [PMID: 26577657]
  19. Science. 1954 Nov 19;120(3125):853 [PMID: 13216184]
  20. Histol Histopathol. 2014 May;29(5):567-87 [PMID: 24327088]
  21. J Clin Microbiol. 2004 Apr;42(4):1829-31 [PMID: 15071062]
  22. Clin Infect Dis. 2008 Jul 1;47(1):33-43 [PMID: 18513147]
  23. J Infect Dis. 1999 Dec;180(6):1863-8 [PMID: 10558942]
  24. BMC Infect Dis. 2006 Mar 16;6:51 [PMID: 16542416]
  25. BMC Microbiol. 2013 Apr 12;13:82 [PMID: 23586331]

Word Cloud

Created with Highcharts 10.0.0biofilmBVsamplesvaginalNugentbacterialORCIpolymicrobialtreatmentbetterbacteriascore4dispersed53OBJECTIVES:BacterialvaginosischaracterisedchangemicrobialcompositionvaginaBV-associatedorganismsoutnumberhealth-associatedspeciesformepitheliumpossiblyexplainingdifficultiesantibioticunderstandingemphasismaycontributediagnosisMETHODS:purposeevaluatedassociationpresencefluorescencesituhybridisationFISHscoring463slides120participantsparticipatingclinicaltrialRwandaRESULTS:detectedhalfusinguniversalprobecontained541%820%accompanied995%oddsincreasedand/orpresent210probabilityhighevenhighercombinationadherentvisualised75613429highestpart1193993608CONCLUSIONS:studyalthoughcomprehensivestudyingprovidedstrongindicationtowardsimportancesymbiosisTRIALREGISTRATIONNUMBER:NCT01796613fruitfulalliance:synergyvaginosis-associatedANTIBIOTICSENSITIVITYBACTERIALVAGINOSISDIAGNOSISGENITALTRACTINFECTMICROBIOLOGY

Similar Articles

Cited By